Companies listed below are contacted on a quarterly basis to review their listing and provide any updates.
Last updated 4/24/2023
Abbvie |
GlaxoSmithKline |
Adaptive Biotechnologies Karuna Craig Patient Access and Reimbursement Manager kcraig@adaptivebiotech.com Patient Hotline (855) 236 9230 Clinical Services (888) 552-8988 https://www.clonoseq.com/adaptive-assist |
Guardant Health Joana Buxhaku Account Executive, Boston North – MA, NH, ME, VT Mobile +1 781 219 8511 Email: clientservices@guardanthealth.com |
Agios Pharmaceuticals Nefar Moran Patient Support Manager Nefar.moran@agios.com 1-800-951-3889 My Agios Patient Services |
Heron Therapeutics CINVANTI® (aprepitant) injectable emulsion |
Alexion Jen Ulven Field Reimbursement Manager 1-904-874-3344 |
Incyte Marcy Gingerich Field Access Manager, McKesson 740-405-2240 Marcy.Gingerich@McKesson.com
Jakafi (ruxolitinib) Pemazyre (pemigatinib) Zynyz (retifanlimab-dlwr) 855-452-5234
Monjuvi (tafasitamab-cxix) 855-421-6172
|
AMAG Pharmaceuticals
Feraheme Assist Feraheme IV Iron Mariaelena Galie Senior Manager, Patient Services 267-275-1185 |
Ipsen Somatuline Depot(Lanreotide), and Onivyde(Irinotecan Liposome Injection) Patient Access services: www.ipsencares.com |
Amgen Field Reimbursement Specialist 781-815-2694 |
Janssen Janssen CompassTM support program dedicated to patients who have been prescribed either ERLEADA® (apalutamide), DARZALEX® (daratumumab), or DARZALEX Faspro® (daratumumab and hyaluronidase-fihj) https://www.janssencompass.com |
Astellas |
Jazz Pharmaceuticals |
AstraZeneca/MedImmune Jenifer N. McNulty Joann Dousa, RPh, AE-C Field Reimbursement Manager, Oncology Connecticut, Upstate New York, Western MA Cell: 508-813-2834 Joann.Dousa@astrazeneca.com |
Karyopharm Therapeutics Jacqueline Buckley Corporate Account Director 85 Wells Avenue Suite 210 Newton MA 02459 Cell: 774- 236-0231 jbuckley@karyopharm.com XPOVIO® (selinexor) For HCPs: www.XPOVIOpro.com https://www.karyforward.com |
Aveo Oncology Caroline Ward, RN, BSN Oncology Account Manager-New England cward@aveooncology.com 603-707-6223 Product: Fotivda (tivozanib) AVEO ACE Program- Access Center of Excellence www.fotivda.com to enroll 1-833-Fotivda (1-833-368-4832) |
Lilly USA Verzenio.com 1-844-verzenio (1-844-837-9364) Lilly Cares Foundation Lillycares.com 1-800-545-6962 |
Bayer Xofigo Patient Assistance Vitrakvi Patient Assistance |
Merck Michael Keyes Field Reimbursement Manager Mobile: (814) 823-3097 Email: michael.keyes@merck.com Mark Montello Mark.Montello@merck.com |
BeiGene |
Novartis Oncology Elizabeth Gugliotta Associate Director Access & Reimbursement Elizabeth.Gugliotta@novartis.com Cell: 401-480-9905 https://copay.novartisoncology.com |
Blueprint Medicines Fred Richards Key Account Manager – New England Blueprint Medicines 781-258-1457 frichards@blueprintmedicines.com |
|
BMS Access Support Manager, Access & Reimbursement Manager Oncology Hematology |
Oncopeptides PEPAXTO (melphalan flufenamide) |
Boehringer-Ingelheim Cathy Berry For more information on the BI Cares Foundation, call 1-855-297-5906 or visit www.boehringer-ingelheim.us/our-responsibility/patient-assistance-program |
Pharmacyclics Field Access Specialist – Northeast Cell: 603-777-6362 Email: Jason.hart@abbvie.com IMBRUVICA (ibrutinib) Patient Access & Support Services: www.imbruvicabyyourside.com |
Caris Life Sciences Nicole Esposito Account Manager Mobile: 207-303-4204 Email: nespositol@carisls.com Patient Access Page: https://www.carislifesciences.com/patients/ Patient Financial Services: https://www.carislifesciences.com/patients/financial-services/ |
Pfizer Field Reimbursement Manager Pfizer Patient Assistance: Besponsa, Bosulif, Braftovi, Daurismo, Ibrance, Inlyta, Lorbrena, Mektovi, Mylotarg, Retacrit, Talzenna, Vizimpro, Xalkori Reimbursement Support and Co-pay assistance only: Aromasin, Nivestym, Nyvepria, Ruxience, Trazimera, Zirabev |
Clovis Oncology Katheryne Murray Cell: 860-876-5568 Rubraca® (rucaparib) |
Puma Biotechnology Daniel Coffey |
Coherus Biosciences, Inc. |
Regeneron |
Daiichi Sankyo Jill Coyle, MBA, BSN, RN Senior Oncology Territory Manager Oncology Breast 211 Mount Airy Road Basking Ridge, NJ 07920 Mobile +207-272-2598 icoyle@dsi.com Products: Injectafer, Enhertu and Turaliohttps://dsiaccesscentral.com/ |
Rigel Pharmaceuticals Kent Main |
Dova Pharmaceuticals Richard DeBone |
Sandoz Biopharmaceuticals |
Eisai Niya Prabhu Sr Manager, Access & Reimbursement niya_prabhu@eisai.com 917.232.5956 Lenvima and Halaven Eisai Assistance Program For program and eligibility information, and to review the program terms and conditions, please visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724) |
Sanofi Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase) |
EMD Serono Walter Serafin, MA, BA Associate Director, Field Patient Services - Oncology EMD Serono, Inc. Mobile: (339) 214-6080 Office: (913) 322-6063 One Technology Place For Bavencio: CoverOne.com Phone: (844) Cover1 or (844) 826-8371 Monday-Friday: 8:00am-8:00pm ET
For Tepmetko: OncNavigationCenter.com Phone: 1-844-662-3631 (844-ONC-EMD1) Monday–Friday: 8:00 am–8:00 pm ET |
Seagen Michelle L. Vallee Senior Oncology Account Manager (207)229-6702 855.4SECURE (855.473.2873), Option 1ADCETRIS® (brentuximab vedotin) PADCEV™ (enfortumab vedotin-ejfv) (See Astellas) TUKYSA®(tucatinib) Tivdak™ (tisotumab vedotin-tftv) |
Epizyme Scott Obenshain, MBA Associate Director of Epigenetic Therapy sobenshain@epizyme.com (716) 998-5662(cell) TAZVERIK™ (tazemetostat) EpizymeNOW or 1-833-4EPINOW (437-4669) |
Servier For help with access and financial assistance, call 800-813-5905 or visit ServierOne.com. |
Exelixis Michele Sofarelli Luther Associate Director, Patient Access CABOMETYX.com |
Sobi Kara Olenio – Health System Director Kara.Olenio@sobi.com 603-843-7336 Gamifant® (emapalumab-lzsg)For Caregivers & Patients (gamifantcares.com) |
Genentech Cell: 475-254-6532 E-mail: Villarreal.Paul@gene.com Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab) Subcutaneous Products: HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human) |
Stemline Therapeutics Taiho Oncology Bob Stewart |
Genomic Health
Dan Monteith |
Deborah Looney Field Access Director Ph: 617-543-9736 deborah.looney@takeda.com Takeda Oncology Here2Assist™ |
Gilead Melissa McLean 1-844-454-5483 TRODELVY |
Teva Pharmaceutical Industries Ltd. Kate Friday Kate.Friday@tevapharm.com US ACT Parsippany, NJ |
TG Therapeutics Kelly Bucklen 401.261.5262 Ukoniq (Umbralisib) |
Other Specialty Contacts
Acredo Specialty Pharmacy Jeremy Boehm
Sr. Account Director
Accredo Specialty Pharmacy
M: 781-980-2179
F: 855-817-2712
jboehm@express-scripts.com
Diplomat Specialty Pharmacy
Yakini Brown
Pharmacy Liaison
P. 810.768.9115
F. 810.262.0261
ybrown@diplomat.is
Foundation Medicine
Bill Walsh
Senior Account Executive | New England
C: 603.391.8174
Client Services: 888.988.3639
Foundation Medicine, Inc.
150 Second Street, Cambridge, MA 02141
bwalsh@foundationmedicine.comKroger Specialty Pharmacy
Kevin B. Penner
Oncology Specialty Account Manager- New England
Phone: 860-227-3458
Fax: 888-315-3270
kevin.penner@krogerhealth.com
www.krogerspecialtypharmacy.com